Assessment for Acquired Pyruvate Kinase Deficiency
Characterization Of Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 100 patients (estimated)
- Sponsors
- Massachusetts General Hospital
- Collaborators
- Agios Pharmaceuticals, Inc.
- Tags
- Laboratory Assay
- Trial Type
- Observational
- Last Update
- 1 month ago
- SparkCures ID
- 1630
- NCT Identifier
- NCT04902833
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.